UBS AM’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.4K Buy
+848
New +$14.2K ﹤0.01% 3754

Other funds holding CBIO

UBS AM's CBIO Position: Q3 2026 in Review

UBS AM opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 848 shares worth $12.4K. The stake represents ﹤0.01% of the portfolio and ranks #3754 among its holdings.

105 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • UBS AM held 848 shares of Crescent Biopharma worth $12.4K as of Q3 2026.
  • Crescent Biopharma was a new UBS AM position in Q3 2026.
  • Crescent Biopharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3754 holding.
  • 105 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.